These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22934977)

  • 21. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
    Oktem IM; Gulay Z; Bicmen M; Gur D;
    Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Characterization of Extended-Spectrum β-Lactamase
    Shash RY; Elshimy AA; Soliman MY; Mosharafa AA
    Am J Trop Med Hyg; 2019 Mar; 100(3):522-528. PubMed ID: 30594263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance in gram-negative bacteria: Enterobacteriaceae.
    Paterson DL
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S20-8; discussion S64-73. PubMed ID: 16813978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.
    Rodríguez-Baño J; Miró E; Villar M; Coelho A; Gozalo M; Borrell N; Bou G; Conejo MC; Pomar V; Aracil B; Larrosa N; Agüero J; Oliver A; Fernández A; Oteo J; Pascual A; Navarro F
    J Infect; 2012 Feb; 64(2):176-83. PubMed ID: 22138600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
    Lartigue MF; Zinsius C; Wenger A; Bille J; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2855-60. PubMed ID: 17470647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
    Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance.
    Pitout JD
    Front Microbiol; 2012; 3():9. PubMed ID: 22294983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).
    Castanheira M; Mendes RE; Rhomberg PR; Jones RN
    Microb Drug Resist; 2008 Sep; 14(3):211-6. PubMed ID: 18707552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
    Woodford N; Ward ME; Kaufmann ME; Turton J; Fagan EJ; James D; Johnson AP; Pike R; Warner M; Cheasty T; Pearson A; Harry S; Leach JB; Loughrey A; Lowes JA; Warren RE; Livermore DM
    J Antimicrob Chemother; 2004 Oct; 54(4):735-43. PubMed ID: 15347638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
    Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
    Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-lactamases in Enterobacteriaceae infections in children.
    Moxon CA; Paulus S
    J Infect; 2016 Jul; 72 Suppl():S41-9. PubMed ID: 27180312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
    Seiffert SN; Hilty M; Kronenberg A; Droz S; Perreten V; Endimiani A
    J Antimicrob Chemother; 2013 Oct; 68(10):2249-54. PubMed ID: 23759671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.